PRESS RELEASE published on 08/27/2026 at 18:59, 1 month 11 days ago Inside Information / Other news releases ABIONYX Pharma updates activity and cash position for H1 2026: revenue of €1.9M, cash balance of €26.9M before Research Tax Credits and grants. Company focuses on innovative therapies for sepsis Revenue Cash Position Innovative Therapies ABIONYX Pharma Activity Update
BRIEF published on 07/06/2026 at 20:05, 3 months 1 day ago ABIONYX: Details on Share Capital and Voting Rights Euronext Paris Share Capital Voting Rights AMF ABIONYX
BRIEF published on 07/06/2026 at 20:05, 3 months 1 day ago ABIONYX Monthly Voting Rights Update Euronext Paris Share Capital Voting Rights Financial Update ABIONYX Pharma
PRESS RELEASE published on 07/06/2026 at 20:00, 3 months 1 day ago Inside Information / Other news releases ABIONYX Pharma discloses monthly statement of total voting rights and shares. Company focuses on innovative medicines development with lipid science expertise Shares Total Voting Rights ABIONYX Pharma Innovative Medicines Lipid Science
BRIEF published on 07/06/2026 at 19:19, 3 months 1 day ago ABIONYX's Half-Yearly Review of the Liquidity Contract Liquidity Transactions TP ICAP Actions ABIONYX Pharma
BRIEF published on 06/30/2026 at 19:13, 3 months 7 days ago ABIONYX Pharma is expanding rapidly following its General Meeting ABIONYX Pharma Sepsis CER-001 General Assembly 2026 ApoA-I Platform
BRIEF published on 06/30/2026 at 19:13, 3 months 7 days ago ABIONYX Pharma Secures Funding to Advance Sepsis Treatment ABIONYX Pharma CER-001 Financial Funding Sepsis Treatment ApoA-I Platform
PRESS RELEASE published on 06/30/2026 at 19:08, 3 months 7 days ago Inside Information / Other news releases ABIONYX Pharma scales up operations after securing resources, focusing on value creation in inflammation and sepsis treatment. Updates on pivotal clinical trial, financial visibility, and scientific platform development Financial Resources Clinical Trial ABIONYX Pharma Sepsis Inflammation Treatment
BRIEF published on 06/18/2026 at 07:35, 3 months 20 days ago ABIONYX Pharma successfully completes its capital increase Capital Increase Clinical Trial Bond Financing Sepsis Fenja Capital
BRIEF published on 06/18/2026 at 07:35, 3 months 20 days ago ABIONYX Pharma Completes Successful EUR 33 Million Financing Capital Increase Bond Financing ABIONYX Pharma Fenja Capital Sepsis Research
Published on 10/07/2026 at 23:30, 8 hours 21 minutes ago Algo Grande Copper Core Testing Shows Mineralized Skarn is Denser and More Chargeable Than Host Rocks; Ground Gravity Survey to Begin at Adelita
Published on 10/07/2026 at 22:05, 9 hours 46 minutes ago Loar Holdings Inc. Announces Date and Time for Third Quarter 2026 Earnings and Conference Call
Published on 10/07/2026 at 17:00, 14 hours 51 minutes ago BlackBerry Radar Expands Asset Intelligence Platform with Dynamic Pairing
Published on 10/07/2026 at 15:30, 16 hours 21 minutes ago Gold Port Announces Marketing Agreement with NAI Interactive Ltd.
Published on 10/07/2026 at 14:30, 17 hours 21 minutes ago Secure Blockchain's Agentic Solutions Signs Financial Services Firm, Expanding Enterprise AI Into Corporate Finance
Published on 10/08/2026 at 07:30, 21 minutes ago AGRANA posts significantly improved first-half results
Published on 10/08/2026 at 07:05, 46 minutes ago Subway® unveils Blueprint, a reimagined restaurant and brand experience for EMEA
Published on 10/08/2026 at 07:00, 51 minutes ago Newron Provides Update on FDA Clinical Hold and Phase 3 ENIGMA-TRS Development Program
Published on 10/08/2026 at 07:00, 51 minutes ago Press release: Ground-breaking ceremony for 122 apartments in the Nordbau
Published on 10/08/2026 at 06:40, 1 hour 11 minutes ago HIZENERGY Presented Full-Stack C&I Energy Storage Solutions at Two European Exhibitions in September
Published on 10/07/2026 at 18:19, 13 hours 31 minutes ago Outstanding shares and voting rights statement at 30 September 2026
Published on 10/07/2026 at 17:45, 14 hours 6 minutes ago Availability of the Pre-Q3 2026 Sales Communication
Published on 10/07/2026 at 15:54, 15 hours 57 minutes ago Disclosure of Share Capital and Voting Rights as of September 30, 2026
Published on 10/07/2026 at 08:15, 23 hours 36 minutes ago EURAZEO TO ACQUIRE MIYA WATER, A GLOBAL SPECIALIST IN EFFICIENT WATER MANAGEMENT SOLUTIONS
